Literature DB >> 17390134

A direct ROI quantification method for inherent PVE correction: accuracy assessment in striatal SPECT measurements.

Eleonora Vanzi1, Maria Teresa De Cristofaro, Silvia Ramat, Barbara Sotgia, Mario Mascalchi, Andreas Robert Formiconi.   

Abstract

PURPOSE: The clinical potential of striatal imaging with dopamine transporter (DAT) SPECT tracers is hampered by the limited capability to recover activity concentration ratios due to partial volume effects (PVE). We evaluated the accuracy of a least squares method that allows retrieval of activity in regions of interest directly from projections (LS-ROI).
METHODS: An Alderson striatal phantom was filled with striatal to background ratios of 6:1, 9:1 and 28:1; the striatal and background ROIs were drawn on a coregistered X-ray CT of the phantom. The activity ratios of these ROIs were derived both with the LS-ROI method and with conventional SPECT EM reconstruction (EM-SPECT). Moreover, the two methods were compared in seven patients with motor symptoms who were examined with N-3-fluoropropyl-2-beta-carboxymethoxy-3-beta-(4-iodophenyl) (FP-CIT) SPECT, calculating the binding potential (BP).
RESULTS: In the phantom study, the activity ratios obtained with EM-SPECT were 3.5, 5.3 and 17.0, respectively, whereas the LS-ROI method resulted in ratios of 6.2, 9.0 and 27.3, respectively. With the LS-ROI method, the BP in the seven patients was approximately 60% higher than with EM-SPECT; a linear correlation between the LS-ROI and the EM estimates was found (r=0.98, p=0.03).
CONCLUSION: The LS-ROI PVE correction capability is mainly due to the fact that the ill-conditioning of the LS-ROI approach is lower than that of the EM-SPECT one. The LS-ROI seems to be feasible and accurate in the examination of the dopaminergic system. This approach can be fruitful in monitoring of disease progression and in clinical trials of dopaminergic drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390134     DOI: 10.1007/s00259-007-0404-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  39 in total

1.  Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT.

Authors:  Marine Soret; Pierre Malick Koulibaly; Jacques Darcourt; Sébastien Hapdey; Irène Buvat
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

2.  Absolute quantification in dopaminergic neurotransmission SPECT using a Monte Carlo-based scatter correction and fully 3-dimensional reconstruction.

Authors:  Albert Cot; Carles Falcón; Cristina Crespo; Josep Sempau; Deborah Pareto; Santiago Bullich; Francisco Lomeña; Francisco Calviño; Javier Pavía; Domènec Ros
Journal:  J Nucl Med       Date:  2005-09       Impact factor: 10.057

3.  Partial volume effect compensation for quantitative brain SPECT imaging.

Authors:  Yong Du; Benjamin M W Tsui; Eric C Frey
Journal:  IEEE Trans Med Imaging       Date:  2005-08       Impact factor: 10.048

4.  Simultaneous recovery of size and radioactivity concentration of small spheroids with PET data.

Authors:  C H Chen; R F Muzic; A D Nelson; L P Adler
Journal:  J Nucl Med       Date:  1999-01       Impact factor: 10.057

5.  Effect of spatial resolution on SPECT quantification values.

Authors:  A Kojima; M Matsumoto; M Takahashi; Y Hirota; H Yoshida
Journal:  J Nucl Med       Date:  1989-04       Impact factor: 10.057

6.  A new fast algorithm for the evaluation of regions of interest and statistical uncertainty in computed tomography.

Authors:  R H Huesman
Journal:  Phys Med Biol       Date:  1984-05       Impact factor: 3.609

7.  A phantom to assess quantitative recovery of positron tomographs.

Authors:  B E Cooke; A C Evans
Journal:  J Comput Assist Tomogr       Date:  1983-10       Impact factor: 1.826

8.  Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography.

Authors:  T Chaly; V Dhawan; K Kazumata; A Antonini; C Margouleff; J R Dahl; A Belakhlef; D Margouleff; A Yee; S Wang; G Tamagnan; J L Neumeyer; D Eidelberg
Journal:  Nucl Med Biol       Date:  1996-11       Impact factor: 2.408

9.  Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.

Authors:  R B Innis; J P Seibyl; B E Scanley; M Laruelle; A Abi-Dargham; E Wallace; R M Baldwin; Y Zea-Ponce; S Zoghbi; S Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Anatomic standardization: linear scaling and nonlinear warping of functional brain images.

Authors:  S Minoshima; R A Koeppe; K A Frey; D E Kuhl
Journal:  J Nucl Med       Date:  1994-09       Impact factor: 10.057

View more
  7 in total

1.  Improved regional activity quantitation in nuclear medicine using a new approach to correct for tissue partial volume and spillover effects.

Authors:  Stephen C Moore; Sudeepti Southekal; Mi-Ae Park; Sarah J McQuaid; Marie Foley Kijewski; Stefan P Müller
Journal:  IEEE Trans Med Imaging       Date:  2011-09-29       Impact factor: 10.048

2.  Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy.

Authors:  Roberto Sciagrà; Alessandro Passeri; Fabrizio Cipollini; Helga Castagnoli; Iacopo Olivotto; Cyrill Burger; Franco Cecchi; Alberto Pupi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-27       Impact factor: 9.236

3.  Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use?

Authors:  Habib Zaidi; Georges El Fakhri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07       Impact factor: 9.236

4.  Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation.

Authors:  Cristina Crespo; Judith Gallego; Albert Cot; Carles Falcón; Santiago Bullich; Deborah Pareto; Pablo Aguiar; Josep Sempau; Francisco Lomeña; Francisco Calviño; Javier Pavía; Domènec Ros
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-12       Impact factor: 9.236

5.  An energy-optimized collimator design for a CZT-based SPECT camera.

Authors:  Fenghua Weng; Srijeeta Bagchi; Yunlong Zan; Qiu Huang; Youngho Seo
Journal:  Nucl Instrum Methods Phys Res A       Date:  2016-01-11       Impact factor: 1.455

6.  Clinical correlation of the binding potential with 123I-FP-CIT in de novo idiopathic Parkinson's disease patients.

Authors:  Valentina Berti; Alberto Pupi; Silvia Ramat; Eleonora Vanzi; Maria Teresa De Cristofaro; Giannantonio Pellicanò; Francesco Mungai; Paolo Marini; Sandro Sorbi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-23       Impact factor: 9.236

7.  Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease.

Authors:  Valentina Berti; Cristina Polito; Silvia Ramat; Eleonora Vanzi; Maria Teresa De Cristofaro; Giannantonio Pellicanò; Francesco Mungai; Paolo Marini; Andreas Robert Formiconi; Sandro Sorbi; Alberto Pupi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-02       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.